As part of this study, which is a collaboration with Newcastle University and Durham University, O’Brien described an ongoing systematic review of dementia with Lewy bodies/Parkinson’s disease dementia trials, in which controlled trials show that cholinesterase inhibitors may have beneficial cognitive effects while uncontrolled trials suggest that levodopa could be helpful for motor symptoms. This evidence concerns the gene BCHE and dementia.